Juvantia Pharma

Contact
juvantia.com
+358265171500

Oy Juvantia Pharma Ltd.

Lemminkäisenkatu 5, PharmaCity
20520 Turku
Finland
+358265171500
juvantia.com
Contact
Profile Products News
Contact

About Juvantia Pharma

Juvantia Pharma discovers and develops pharmaceuticals for neurological and cardiovascular disorders with the ultimate goal to offer new treatment possibilities and increase safety margins to patients and reduce the costs to society.

Read more about Juvantia Pharma
Facts about Juvantia Pharma
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Juvantia Pharma

Product portfolio

Show all

News about Juvantia Pharma

Juvantia Pharma

05-Oct-2009 | business & finance

Santhera Reports Closing of Juvantia Acquisition and Final Upfront Payment from Partner Biovail

Santhera Pharmaceuticals announced the final closing of the acquisition of Oy Juvantia Pharma Ltd of Turku, Finland. Santhera issued 105,973 previously ...

Read news
Juvantia Pharma

17-Aug-2009 | business & finance

Santhera Acquires Juvantia and Secures All Rights to JP-1730/Fipamezole

Santhera Pharmaceuticals announced that it exercised its option to acquire Oy Juvantia Pharma Ltd of Turku, Finland, the owner of JP-1730/fipamezole. ...

Read news
Juvantia Pharma

12-Nov-2007 | business & finance

Santhera Starts Phase IIb Clinical Trial with JP-1730 in Dyskinesia in Parkinson's Disease

Santhera Pharmaceuticals and Juvantia Pharma Ltd announced that the first patient has been enrolled into a Phase IIb clinical trial to evaluate JP-1730 ( ...

Read news
Juvantia Pharma

07-Sep-2006 | business & finance

Santhera and Juvantia to Collaborate on Development of Phase II Product for Dyskinesia in Parkinson's Disease

Santhera Pharmaceuticals and Juvantia Pharma announced that they have entered into a strategic collaboration to advance the development of Juvantia's ...

Read news
Show more news about Juvantia Pharma

Here you will find Oy Juvantia Pharma Ltd.